A Quebec owner is suing Tesla after her Model 3 heat pump failed after 6 years, costing $4,477. The class action covers all ...

PTC Therapeutics is transitioning its growth engine from legacy drugs to new launches like Sephience, targeting rare genetic diseases with high unmet need. Pipeline catalysts, notably Votoplam for ...

United States Customs and Border Protection is paying General Dynamics to create a prototype of “quantum sensors” alongside a “database with artificial intelligence” designed “to detect illicit ...

New respiratory protection technologies combine sensors, AI analytics and connected dashboards to monitor air quality, worker health and exposure risks in real time across hazardous workplaces.

To join the CNBC Technology Executive Council, go to cnbccouncils.com/tec Walmart is deploying millions of ambient Internet of Things battery-free sensors throughout ...

PTC's annual run-rate growth supports super growth in cash flow for investors. The company's growth is even more impressive, considering the weak manufacturing environment over the last couple of ...

Aug 19 (Reuters) - The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' (PTCT.O), opens new tab oral medication for a rare genetic disorder with limited treatment options, ...

NEW YORK, July 14 (Reuters) - Design software maker Autodesk (ADSK.O), opens new tab said in a regulatory filing on Monday that it plans to pursue its "strategic priorities" and make only "targeted ...

Boston, Massachusetts-based PTC Inc. (PTC) is a software company that aids manufacturing companies in designing, operating, and managing products. Valued at a market cap of $18.8 billion, the company ...